| Product Code: ETC9398601 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Blockbuster Oncology Brands Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Blockbuster Oncology Brands Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Blockbuster Oncology Brands Market - Industry Life Cycle |
3.4 South Korea Blockbuster Oncology Brands Market - Porter's Five Forces |
3.5 South Korea Blockbuster Oncology Brands Market Revenues & Volume Share, By Brands, 2021 & 2031F |
3.6 South Korea Blockbuster Oncology Brands Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 South Korea Blockbuster Oncology Brands Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Korea |
4.2.2 Growing investment in research and development for oncology drugs |
4.2.3 Technological advancements in oncology treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from generic oncology drugs |
4.3.3 High cost associated with oncology treatments |
5 South Korea Blockbuster Oncology Brands Market Trends |
6 South Korea Blockbuster Oncology Brands Market, By Types |
6.1 South Korea Blockbuster Oncology Brands Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.1.4 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Keytruda, 2021- 2031F |
6.1.5 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Perjeta, 2021- 2031F |
6.1.6 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Ibrance, 2021- 2031F |
6.1.7 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Tecentriq, 2021- 2031F |
6.1.8 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Gazyva, 2021- 2031F |
6.1.9 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.1.10 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.2 South Korea Blockbuster Oncology Brands Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.2.3 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.2.4 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Multiple myeloma, 2021- 2031F |
6.2.5 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.6 South Korea Blockbuster Oncology Brands Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Blockbuster Oncology Brands Market Import-Export Trade Statistics |
7.1 South Korea Blockbuster Oncology Brands Market Export to Major Countries |
7.2 South Korea Blockbuster Oncology Brands Market Imports from Major Countries |
8 South Korea Blockbuster Oncology Brands Market Key Performance Indicators |
8.1 Average time to market for new blockbuster oncology drugs |
8.2 Research and development expenditure on innovative oncology treatments |
8.3 Patient satisfaction and outcomes with the use of blockbuster oncology brands |
8.4 Adoption rate of new oncology therapies in South Korea |
8.5 Number of partnerships and collaborations for oncology drug development |
9 South Korea Blockbuster Oncology Brands Market - Opportunity Assessment |
9.1 South Korea Blockbuster Oncology Brands Market Opportunity Assessment, By Brands, 2021 & 2031F |
9.2 South Korea Blockbuster Oncology Brands Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 South Korea Blockbuster Oncology Brands Market - Competitive Landscape |
10.1 South Korea Blockbuster Oncology Brands Market Revenue Share, By Companies, 2024 |
10.2 South Korea Blockbuster Oncology Brands Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here